GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Astria Therapeutics Inc (STU:2090) » Definitions » Net Interest Income (for Banks)

Astria Therapeutics (STU:2090) Net Interest Income (for Banks)


View and export this data going back to 2017. Start your Free Trial

What is Astria Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Astria Therapeutics (STU:2090) Business Description

Traded in Other Exchanges
Address
75 State Street, Suite 1400, Boston, MA, USA, 02109
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.